GIFFIN BRETT A. (Chief Commercial Officer) sold 39.0% of their position (537.00 shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $349.05 — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/9/2023ACC: 0000899243-23-007727
Officer· Chief Commercial Officer
Since Nov 2021
-537.00
Net shares
Net seller
$349.05
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.33K acquired · 1.87K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.33K
Price / share
—
Trade value
—
% of position
2962.2%
2/20/2023
45.00→1.38K
Common Stock
Direct
Shares
−537.00
Price / share
$0.65
Trade value
$349.05
% of position
39.0%
2/22/2023
1.38K→841.00
Total
Net shares
+796.00
Net value
-$349.05
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/20/2023 | M · Option Exercise | +1.33K | — | — | 2962.2% | 45.00 | 1.38K |
| Common Stock Direct | 2/22/2023 | S · Sale | −537.00 | $0.65 | $349.05 | 39.0% | 1.38K | 841.00 |
| Total | +796.00 | -$349.05 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
1.33K shares
Shares
−1.33K
Strike price
Held after
2.67K
Exercisable
—
2/20/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock1.33K shares | 2/20/2023 | M · Option Exercise | −1.33K | — | 2.67K |